Breast cancer awareness month marks a great time to brush up on your knowledge regarding the importance of BRCA gene testing.
BRCA gene testing scans the body for mutations in both the BRCA1 and BRCA2 genes. BRCA1 mutations increase the risk of developing triple-negative breast cancer, while BRCA2 mutations increase the risk of developing diseases such as breast, ovarian, and melanoma cancers.
It's important to note that both the BRCA1 and BRCA2 genes are inherently present in every person, and mutations in these genes do not allow them to function properly. If your family has a history of cancer, you may be inheriting mutated BRCA genes, which is why this sort of gene testing is so critical – especially for at-risk populations.
What types of tests are available?
There are several types of BRCA gene tests available for people who want to get scanned. Some of these tests specifically look for mutations in those two genes, while others check for all known mutations that could cause different types of cancer.
How can someone get tested? DNA is always needed to run an accurate test, typically via either a blood or saliva sample. The results could take up to a month to come in, and it's recommended you seek genetic counseling before and after any testing is submitted. A genetic counselor can help assess your risk before a screening and help you review options post-screening.
What happens if you test positive?
The good news is that a negative test means you do not carry the gene, and so you have nothing to worry about. A positive test, however, means you not only have a chance of developing cancer, but also a 50 percent chance of passing it on to a child. Here are some things you can do if you receive a positive test:
Sinclair Broadcast Group is committed to our viewers' health and well-being, which is why we initiated Sinclair Cares. Every month we'll bring you information about the "Cause of the Month," including topical information, education, awareness, and prevention. October is National Breast Cancer Awareness Month.